BIO applauded Senators Tom Carper and Pat Toomey for introducing COMPETE Act, which will spur biotech capital formation and stimulate innovative research and development. Specifically, BIO President and CEO Jim Greenwood voiced support concerning included provisions which make R&D tax credit permanent while increasing credit rate. Greenwood also commended increased credit in bill for innovative research expenses as well as encouragement of investment in early-stage, R&D-centric businesses.